

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to parathyroid hormone (GO:0071107) | 9.07945663 |
| 2 | keratinization (GO:0031424) | 7.22895345 |
| 3 | cellular response to prostaglandin stimulus (GO:0071379) | 7.04843195 |
| 4 | sympathetic nervous system development (GO:0048485) | 7.03811197 |
| 5 | body morphogenesis (GO:0010171) | 6.93206885 |
| 6 | ganglion development (GO:0061548) | 6.87951694 |
| 7 | diacylglycerol metabolic process (GO:0046339) | 6.68565694 |
| 8 | dopaminergic neuron differentiation (GO:0071542) | 6.27318822 |
| 9 | enteric nervous system development (GO:0048484) | 6.22284557 |
| 10 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 6.22216648 |
| 11 | endothelial cell chemotaxis (GO:0035767) | 5.53194520 |
| 12 | response to prostaglandin E (GO:0034695) | 5.33833383 |
| 13 | cellular response to zinc ion (GO:0071294) | 5.33781121 |
| 14 | post-embryonic morphogenesis (GO:0009886) | 5.33227536 |
| 15 | negative regulation of multicellular organism growth (GO:0040015) | 5.30183627 |
| 16 | cAMP biosynthetic process (GO:0006171) | 5.26765309 |
| 17 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 5.25195402 |
| 18 | adrenergic receptor signaling pathway (GO:0071875) | 5.24603244 |
| 19 | ectodermal placode formation (GO:0060788) | 5.24108327 |
| 20 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.03360682 |
| 21 | response to BMP (GO:0071772) | 4.99824424 |
| 22 | cellular response to BMP stimulus (GO:0071773) | 4.99824424 |
| 23 | cell migration in hindbrain (GO:0021535) | 4.96381732 |
| 24 | metanephric mesenchyme development (GO:0072075) | 4.80795552 |
| 25 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.71348491 |
| 26 | cell migration involved in heart development (GO:0060973) | 4.57330216 |
| 27 | positive regulation of protein kinase C signaling (GO:0090037) | 4.53285332 |
| 28 | kidney mesenchyme development (GO:0072074) | 4.51817180 |
| 29 | positive regulation of vascular permeability (GO:0043117) | 4.49955932 |
| 30 | surfactant homeostasis (GO:0043129) | 4.39641615 |
| 31 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.35524766 |
| 32 | establishment of skin barrier (GO:0061436) | 4.33849263 |
| 33 | endochondral ossification (GO:0001958) | 4.25286069 |
| 34 | replacement ossification (GO:0036075) | 4.25286069 |
| 35 | cell differentiation involved in metanephros development (GO:0072202) | 4.18604672 |
| 36 | venous blood vessel morphogenesis (GO:0048845) | 4.17899456 |
| 37 | metanephric tubule development (GO:0072170) | 4.17813422 |
| 38 | metanephric nephron tubule development (GO:0072234) | 4.17813422 |
| 39 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.16692772 |
| 40 | regulation of cardioblast proliferation (GO:0003264) | 4.16692772 |
| 41 | coronary vasculature morphogenesis (GO:0060977) | 4.16683010 |
| 42 | regulation of endothelial cell chemotaxis (GO:2001026) | 4.12502678 |
| 43 | peptide cross-linking (GO:0018149) | 4.10414505 |
| 44 | protein heterotrimerization (GO:0070208) | 4.07272880 |
| 45 | metanephric nephron epithelium development (GO:0072243) | 4.05298721 |
| 46 | response to prostaglandin (GO:0034694) | 3.97592483 |
| 47 | gamma-aminobutyric acid transport (GO:0015812) | 3.97551949 |
| 48 | atrioventricular valve morphogenesis (GO:0003181) | 3.94526070 |
| 49 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.87160989 |
| 50 | peptidyl-proline hydroxylation (GO:0019511) | 3.86649063 |
| 51 | protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205) | 3.86228081 |
| 52 | heart valve formation (GO:0003188) | 3.85308951 |
| 53 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.81720460 |
| 54 | behavioral response to nicotine (GO:0035095) | 3.81579908 |
| 55 | keratan sulfate catabolic process (GO:0042340) | 3.79063317 |
| 56 | apoptotic process involved in morphogenesis (GO:0060561) | 3.77393153 |
| 57 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.74367213 |
| 58 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.72792508 |
| 59 | regulation of water loss via skin (GO:0033561) | 3.72348410 |
| 60 | positive regulation of p38MAPK cascade (GO:1900745) | 3.70491880 |
| 61 | metanephric epithelium development (GO:0072207) | 3.68892324 |
| 62 | 4-hydroxyproline metabolic process (GO:0019471) | 3.67939809 |
| 63 | nephron tubule development (GO:0072080) | 3.67745660 |
| 64 | collagen fibril organization (GO:0030199) | 3.64306893 |
| 65 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.64238699 |
| 66 | regulation of respiratory gaseous exchange (GO:0043576) | 3.62905983 |
| 67 | negative regulation of cell cycle arrest (GO:0071157) | 3.60089179 |
| 68 | tongue development (GO:0043586) | 3.58573572 |
| 69 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.56955879 |
| 70 | neural crest cell migration (GO:0001755) | 3.56657858 |
| 71 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.55625596 |
| 72 | hemidesmosome assembly (GO:0031581) | 3.54335056 |
| 73 | mesenchymal cell proliferation (GO:0010463) | 3.53895660 |
| 74 | endocardial cushion morphogenesis (GO:0003203) | 3.53821912 |
| 75 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.52152634 |
| 76 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.47748107 |
| 77 | keratinocyte differentiation (GO:0030216) | 3.46403829 |
| 78 | negative regulation of heart growth (GO:0061117) | 3.42767730 |
| 79 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.42767730 |
| 80 | nephron epithelium development (GO:0072009) | 3.41107511 |
| 81 | chemical homeostasis within a tissue (GO:0048875) | 3.29930354 |
| 82 | cellular response to catecholamine stimulus (GO:0071870) | 3.29101256 |
| 83 | cellular response to monoamine stimulus (GO:0071868) | 3.29101256 |
| 84 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.29092403 |
| 85 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.29092403 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.28680625 |
| 87 | bone development (GO:0060348) | 3.28625975 |
| 88 | regulation of p38MAPK cascade (GO:1900744) | 3.26336580 |
| 89 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.25626145 |
| 90 | protein maturation by protein folding (GO:0022417) | 3.25349247 |
| 91 | cochlea morphogenesis (GO:0090103) | 3.24551043 |
| 92 | renal tubule development (GO:0061326) | 3.23891650 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.22965605 |
| 94 | pattern specification involved in kidney development (GO:0061004) | 3.21499533 |
| 95 | phosphate ion transmembrane transport (GO:0035435) | 3.17692763 |
| 96 | cardiac myofibril assembly (GO:0055003) | 3.17197064 |
| 97 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.15227671 |
| 98 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.14353569 |
| 99 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.13383585 |
| 100 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.13383585 |
| 101 | negative regulation of catenin import into nucleus (GO:0035414) | 3.12606211 |
| 102 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.09219438 |
| 103 | genetic imprinting (GO:0071514) | 3.09108379 |
| 104 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.08908833 |
| 105 | ectoderm development (GO:0007398) | 3.04911956 |
| 106 | bone trabecula formation (GO:0060346) | 3.04838041 |
| 107 | camera-type eye morphogenesis (GO:0048593) | 3.04297922 |
| 108 | type B pancreatic cell proliferation (GO:0044342) | 3.02944137 |
| 109 | cellular response to ketone (GO:1901655) | 3.01233387 |
| 110 | mesenchyme morphogenesis (GO:0072132) | 2.99831837 |
| 111 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.99723311 |
| 112 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.99553595 |
| 113 | basement membrane organization (GO:0071711) | 2.99369241 |
| 114 | cellular zinc ion homeostasis (GO:0006882) | 2.99064292 |
| 115 | protein hydroxylation (GO:0018126) | 2.98460898 |
| 116 | lung vasculature development (GO:0060426) | 2.97591813 |
| 117 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.97300896 |
| 118 | desmosome organization (GO:0002934) | 2.96759373 |
| 119 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.96323465 |
| 120 | skin development (GO:0043588) | 2.95614140 |
| 121 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.94474567 |
| 122 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.92834707 |
| 123 | SMAD protein complex assembly (GO:0007183) | 2.92386651 |
| 124 | apoptotic process involved in development (GO:1902742) | 2.91424273 |
| 125 | peripheral nervous system axon ensheathment (GO:0032292) | 2.91258266 |
| 126 | myelination in peripheral nervous system (GO:0022011) | 2.91258266 |
| 127 | protein retention in ER lumen (GO:0006621) | 2.90718343 |
| 128 | heart valve morphogenesis (GO:0003179) | 2.89639429 |
| 129 | regulation of cAMP-mediated signaling (GO:0043949) | 2.88436263 |
| 130 | norepinephrine metabolic process (GO:0042415) | 2.86877036 |
| 131 | embryo implantation (GO:0007566) | 2.86194809 |
| 132 | nephron tubule formation (GO:0072079) | 2.85598806 |
| 133 | cartilage condensation (GO:0001502) | 2.85504525 |
| 134 | cell aggregation (GO:0098743) | 2.85504525 |
| 135 | positive regulation of glomerulus development (GO:0090193) | 2.85010981 |
| 136 | negative regulation of metanephros development (GO:0072217) | 2.84901487 |
| 137 | protein targeting to plasma membrane (GO:0072661) | 2.84408143 |
| 138 | cell communication by electrical coupling (GO:0010644) | 2.83592757 |
| 139 | adult heart development (GO:0007512) | 2.81104275 |
| 140 | skin morphogenesis (GO:0043589) | 2.80130156 |
| 141 | cyclic nucleotide biosynthetic process (GO:0009190) | 2.78957201 |
| 142 | regulation of neuron projection regeneration (GO:0070570) | 2.78045680 |
| 143 | regulation of axon regeneration (GO:0048679) | 2.78045680 |
| 144 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.77972120 |
| 145 | response to monoamine (GO:0071867) | 2.77391322 |
| 146 | response to catecholamine (GO:0071869) | 2.77391322 |
| 147 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.76999828 |
| 148 | cartilage morphogenesis (GO:0060536) | 2.75886038 |
| 149 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.75816172 |
| 150 | regulation of axon guidance (GO:1902667) | 2.74414086 |
| 151 | organic cation transport (GO:0015695) | 2.74261328 |
| 152 | embryonic hindlimb morphogenesis (GO:0035116) | 2.74160226 |
| 153 | sarcomere organization (GO:0045214) | 2.73415420 |
| 154 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.71982402 |
| 155 | cranial nerve morphogenesis (GO:0021602) | 2.71827866 |
| 156 | multicellular organismal water homeostasis (GO:0050891) | 2.70885482 |
| 157 | positive regulation of metanephros development (GO:0072216) | 2.69500806 |
| 158 | negative regulation of protein localization to cell surface (GO:2000009) | 2.65939243 |
| 159 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.65552440 |
| 160 | epidermal cell differentiation (GO:0009913) | 2.64874134 |
| 161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.61299821 |
| 162 | hair cycle (GO:0042633) | 2.58648340 |
| 163 | molting cycle (GO:0042303) | 2.58648340 |
| 164 | phosphate ion transport (GO:0006817) | 2.56507461 |
| 165 | myelin maintenance (GO:0043217) | 2.53594441 |
| 166 | epidermis development (GO:0008544) | 2.53251265 |
| 167 | dermatan sulfate biosynthetic process (GO:0030208) | 2.52928110 |
| 168 | glomerular filtration (GO:0003094) | 2.52911945 |
| 169 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.51355511 |
| 170 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.47615199 |
| 171 | dermatan sulfate metabolic process (GO:0030205) | 2.47335466 |
| 172 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.46064094 |
| 173 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.43692801 |
| 174 | protein carboxylation (GO:0018214) | 2.43692801 |
| 175 | water homeostasis (GO:0030104) | 2.43047993 |
| 176 | cranial nerve structural organization (GO:0021604) | 2.43023988 |
| 177 | renal filtration (GO:0097205) | 2.42042639 |
| 178 | linoleic acid metabolic process (GO:0043651) | 2.40020085 |
| 179 | establishment of tissue polarity (GO:0007164) | 2.37298856 |
| 180 | establishment of planar polarity (GO:0001736) | 2.37298856 |
| 181 | Notch signaling involved in heart development (GO:0061314) | 2.37134489 |
| 182 | regulation of protein kinase C signaling (GO:0090036) | 2.36166513 |
| 183 | glomerular basement membrane development (GO:0032836) | 2.35191519 |
| 184 | collecting duct development (GO:0072044) | 2.34097352 |
| 185 | regulation of vascular permeability (GO:0043114) | 2.31827755 |
| 186 | chondroitin sulfate catabolic process (GO:0030207) | 2.31760157 |
| 187 | aorta morphogenesis (GO:0035909) | 2.25739998 |
| 188 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.24556434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.64523871 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.44732373 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.93239998 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.69806002 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.08348595 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.88821048 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.69767506 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.69315103 |
| 9 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.24822999 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13381560 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13381560 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13267333 |
| 13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.08544808 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07082388 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.04995974 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00482857 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.99320123 |
| 18 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.98421027 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.88340677 |
| 20 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.86700975 |
| 21 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.86607682 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.86234085 |
| 23 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.84774571 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83352809 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78860677 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72140953 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71681938 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.70312899 |
| 29 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.70236766 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69853665 |
| 31 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65654457 |
| 32 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.64741894 |
| 33 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.64115911 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61767308 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61235095 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60909301 |
| 37 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.59416528 |
| 38 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.59210653 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.58779912 |
| 40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.58245858 |
| 41 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.58245858 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58218752 |
| 43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57840310 |
| 44 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.56083655 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.55605084 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.55304401 |
| 47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.53289917 |
| 48 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52317647 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.49511195 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48831725 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43274756 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.41357876 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40999239 |
| 54 | ATF3_27146783_Chip-Seq_COLON_Human | 1.40934164 |
| 55 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40508264 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40326488 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39371725 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39135030 |
| 59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36551298 |
| 60 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.36147075 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35852943 |
| 62 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.35825380 |
| 63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34355682 |
| 64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.33165925 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32946733 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31301261 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30599392 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29713080 |
| 69 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29047019 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27228864 |
| 71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26598629 |
| 72 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25895035 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25826404 |
| 74 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.20345319 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20151471 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18842702 |
| 77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17567580 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17404458 |
| 79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16987182 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16771148 |
| 81 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.15948887 |
| 82 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15732097 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15554764 |
| 84 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13351518 |
| 85 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13317143 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13155201 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12377105 |
| 88 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10866853 |
| 89 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.09942644 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08044433 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06887272 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05858806 |
| 93 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05318698 |
| 94 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03979139 |
| 95 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03873945 |
| 96 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02896854 |
| 97 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02588234 |
| 98 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02304716 |
| 99 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01796016 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01008247 |
| 101 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00138907 |
| 102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99920909 |
| 103 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99318108 |
| 104 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98557701 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98215598 |
| 106 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97693325 |
| 107 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97550921 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97541814 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97222037 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97202926 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95797456 |
| 112 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95366654 |
| 113 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.95097014 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94969966 |
| 115 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.94718791 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94165284 |
| 117 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93686524 |
| 118 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93330110 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93040002 |
| 120 | P68_20966046_ChIP-Seq_HELA_Human | 0.92906434 |
| 121 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.92713256 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92539550 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91623732 |
| 124 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90840515 |
| 125 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90647890 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90429787 |
| 127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90327309 |
| 128 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.90226952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003123_paternal_imprinting | 6.24648774 |
| 2 | MP0002638_abnormal_pupillary_reflex | 4.86765417 |
| 3 | MP0003787_abnormal_imprinting | 4.83911856 |
| 4 | MP0003122_maternal_imprinting | 4.22360844 |
| 5 | MP0005503_abnormal_tendon_morphology | 4.21833233 |
| 6 | MP0005275_abnormal_skin_tensile | 3.92277524 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 3.25465663 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.21669998 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.76574797 |
| 10 | MP0000751_myopathy | 2.64917298 |
| 11 | MP0005409_darkened_coat_color | 2.51507088 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 2.48826154 |
| 13 | MP0003878_abnormal_ear_physiology | 2.48826154 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.46054455 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.41813574 |
| 16 | MP0004130_abnormal_muscle_cell | 2.30087497 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.07289460 |
| 18 | MP0002060_abnormal_skin_morphology | 2.07113275 |
| 19 | MP0003646_muscle_fatigue | 2.03835340 |
| 20 | MP0005501_abnormal_skin_physiology | 2.03798087 |
| 21 | MP0003279_aneurysm | 2.01664742 |
| 22 | MP0000762_abnormal_tongue_morphology | 1.98805419 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.95938975 |
| 24 | MP0003879_abnormal_hair_cell | 1.84352946 |
| 25 | MP0000749_muscle_degeneration | 1.82238690 |
| 26 | MP0006054_spinal_hemorrhage | 1.81331530 |
| 27 | MP0003121_genomic_imprinting | 1.76282169 |
| 28 | MP0004272_abnormal_basement_membrane | 1.74847096 |
| 29 | MP0003011_delayed_dark_adaptation | 1.73821632 |
| 30 | MP0000579_abnormal_nail_morphology | 1.73631134 |
| 31 | MP0004134_abnormal_chest_morphology | 1.73227913 |
| 32 | MP0009384_cardiac_valve_regurgitation | 1.71471978 |
| 33 | MP0001270_distended_abdomen | 1.68572512 |
| 34 | MP0010386_abnormal_urinary_bladder | 1.65169652 |
| 35 | MP0001958_emphysema | 1.64568482 |
| 36 | MP0006138_congestive_heart_failure | 1.63803726 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.63424915 |
| 38 | MP0000467_abnormal_esophagus_morphology | 1.60114731 |
| 39 | MP0004858_abnormal_nervous_system | 1.58371801 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.58085295 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.54175942 |
| 42 | MP0002127_abnormal_cardiovascular_syste | 1.52698550 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.52593821 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.45723840 |
| 45 | MP0002822_catalepsy | 1.40091079 |
| 46 | MP0009053_abnormal_anal_canal | 1.38622548 |
| 47 | MP0002282_abnormal_trachea_morphology | 1.36055920 |
| 48 | MP0005023_abnormal_wound_healing | 1.35420406 |
| 49 | MP0000767_abnormal_smooth_muscle | 1.34845275 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.34327798 |
| 51 | MP0003942_abnormal_urinary_system | 1.33581683 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.33372703 |
| 53 | MP0002009_preneoplasia | 1.31028377 |
| 54 | MP0005423_abnormal_somatic_nervous | 1.29973849 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.28879915 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.28691753 |
| 57 | MP0000163_abnormal_cartilage_morphology | 1.27867483 |
| 58 | MP0000049_abnormal_middle_ear | 1.26254709 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.25973384 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 1.25559047 |
| 61 | MP0004085_abnormal_heartbeat | 1.25443948 |
| 62 | MP0000230_abnormal_systemic_arterial | 1.23893367 |
| 63 | MP0005508_abnormal_skeleton_morphology | 1.23667194 |
| 64 | MP0000534_abnormal_ureter_morphology | 1.23360521 |
| 65 | MP0003959_abnormal_lean_body | 1.20893534 |
| 66 | MP0002108_abnormal_muscle_morphology | 1.19858374 |
| 67 | MP0005670_abnormal_white_adipose | 1.18649707 |
| 68 | MP0001727_abnormal_embryo_implantation | 1.16219641 |
| 69 | MP0002796_impaired_skin_barrier | 1.15242806 |
| 70 | MP0005171_absent_coat_pigmentation | 1.13472008 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07066697 |
| 72 | MP0010368_abnormal_lymphatic_system | 1.06051676 |
| 73 | MP0002249_abnormal_larynx_morphology | 1.03650692 |
| 74 | MP0004036_abnormal_muscle_relaxation | 1.03059164 |
| 75 | MP0003091_abnormal_cell_migration | 1.02933887 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 1.01055618 |
| 77 | MP0004484_altered_response_of | 0.98961532 |
| 78 | MP0002933_joint_inflammation | 0.98805508 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.97017947 |
| 80 | MP0004087_abnormal_muscle_fiber | 0.96634277 |
| 81 | MP0002115_abnormal_skeleton_extremities | 0.95961680 |
| 82 | MP0001756_abnormal_urination | 0.95334601 |
| 83 | MP0009672_abnormal_birth_weight | 0.94444587 |
| 84 | MP0005385_cardiovascular_system_phenoty | 0.94279118 |
| 85 | MP0001544_abnormal_cardiovascular_syste | 0.94279118 |
| 86 | MP0003941_abnormal_skin_development | 0.93167742 |
| 87 | MP0005330_cardiomyopathy | 0.92779013 |
| 88 | MP0002972_abnormal_cardiac_muscle | 0.92656167 |
| 89 | MP0008569_lethality_at_weaning | 0.92213958 |
| 90 | MP0005369_muscle_phenotype | 0.91550180 |
| 91 | MP0005647_abnormal_sex_gland | 0.91304424 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.91303993 |
| 93 | MP0003385_abnormal_body_wall | 0.90233747 |
| 94 | MP0002751_abnormal_autonomic_nervous | 0.89838951 |
| 95 | MP0002106_abnormal_muscle_physiology | 0.86809691 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 0.86760554 |
| 97 | MP0004885_abnormal_endolymph | 0.85823363 |
| 98 | MP0004381_abnormal_hair_follicle | 0.83977809 |
| 99 | MP0001348_abnormal_lacrimal_gland | 0.81906987 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.81674077 |
| 101 | MP0010771_integument_phenotype | 0.81251184 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.81008500 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.80607008 |
| 104 | MP0000566_synostosis | 0.80210864 |
| 105 | MP0003283_abnormal_digestive_organ | 0.78922345 |
| 106 | MP0000377_abnormal_hair_follicle | 0.78213379 |
| 107 | MP0001243_abnormal_dermal_layer | 0.78061109 |
| 108 | MP0000759_abnormal_skeletal_muscle | 0.75958221 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.75398540 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.75071862 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.74522371 |
| 112 | MP0000266_abnormal_heart_morphology | 0.74264304 |
| 113 | MP0004233_abnormal_muscle_weight | 0.73434981 |
| 114 | MP0002295_abnormal_pulmonary_circulatio | 0.73047725 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.71979181 |
| 116 | MP0002735_abnormal_chemical_nociception | 0.71887970 |
| 117 | MP0009703_decreased_birth_body | 0.71849870 |
| 118 | MP0000750_abnormal_muscle_regeneration | 0.71598680 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.70834292 |
| 120 | MP0004859_abnormal_synaptic_plasticity | 0.70470466 |
| 121 | MP0005620_abnormal_muscle_contractility | 0.69072216 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.66742747 |
| 123 | MP0002971_abnormal_brown_adipose | 0.65941073 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.65417902 |
| 125 | MP0009931_abnormal_skin_appearance | 0.65318182 |
| 126 | MP0003136_yellow_coat_color | 0.65082353 |
| 127 | MP0000747_muscle_weakness | 0.65057012 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.64617142 |
| 129 | MP0002269_muscular_atrophy | 0.64073416 |
| 130 | MP0002109_abnormal_limb_morphology | 0.63896479 |
| 131 | MP0000538_abnormal_urinary_bladder | 0.63403742 |
| 132 | MP0002128_abnormal_blood_circulation | 0.62969902 |
| 133 | MP0003935_abnormal_craniofacial_develop | 0.62884748 |
| 134 | MP0002113_abnormal_skeleton_development | 0.62744359 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.62434213 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.62238143 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.61655451 |
| 138 | MP0000026_abnormal_inner_ear | 0.61441308 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.61013364 |
| 140 | MP0002925_abnormal_cardiovascular_devel | 0.60509973 |
| 141 | MP0000249_abnormal_blood_vessel | 0.59476365 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.59217805 |
| 143 | MP0001542_abnormal_bone_strength | 0.59208705 |
| 144 | MP0005164_abnormal_response_to | 0.58553649 |
| 145 | MP0002111_abnormal_tail_morphology | 0.57989242 |
| 146 | MP0001614_abnormal_blood_vessel | 0.55799174 |
| 147 | MP0003948_abnormal_gas_homeostasis | 0.55665271 |
| 148 | MP0003755_abnormal_palate_morphology | 0.55518231 |
| 149 | MP0000920_abnormal_myelination | 0.53636569 |
| 150 | MP0008770_decreased_survivor_rate | 0.53198632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malnutrition (HP:0004395) | 8.77082418 |
| 2 | Enlarged penis (HP:0000040) | 7.30317582 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.35060315 |
| 4 | Abnormality of nail color (HP:0100643) | 5.32331223 |
| 5 | Menstrual irregularities (HP:0000858) | 5.29172348 |
| 6 | Hyperthyroidism (HP:0000836) | 4.55219130 |
| 7 | Rhinitis (HP:0012384) | 4.53963168 |
| 8 | Hypercortisolism (HP:0001578) | 4.35569787 |
| 9 | Growth hormone excess (HP:0000845) | 4.23232895 |
| 10 | Steatorrhea (HP:0002570) | 4.21856050 |
| 11 | Macroorchidism (HP:0000053) | 4.21644009 |
| 12 | Agitation (HP:0000713) | 4.15538230 |
| 13 | Axonal loss (HP:0003447) | 4.11243352 |
| 14 | Soft skin (HP:0000977) | 4.04837296 |
| 15 | Striae distensae (HP:0001065) | 3.99740271 |
| 16 | Cranial hyperostosis (HP:0004437) | 3.99141550 |
| 17 | Thin bony cortex (HP:0002753) | 3.68475384 |
| 18 | Epiphyseal dysplasia (HP:0002656) | 3.67314057 |
| 19 | Testicular neoplasm (HP:0010788) | 3.60300079 |
| 20 | Hyperphosphatemia (HP:0002905) | 3.57763712 |
| 21 | Alopecia of scalp (HP:0002293) | 3.54979285 |
| 22 | Protrusio acetabuli (HP:0003179) | 3.52517675 |
| 23 | Palmoplantar hyperkeratosis (HP:0000972) | 3.49958109 |
| 24 | Polycythemia (HP:0001901) | 3.42538432 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.42508904 |
| 26 | Hyperparathyroidism (HP:0000843) | 3.41061548 |
| 27 | Nuclear cataract (HP:0100018) | 3.36873132 |
| 28 | Osteoarthritis (HP:0002758) | 3.36648264 |
| 29 | Premature rupture of membranes (HP:0001788) | 3.34823029 |
| 30 | Hypoplastic ischia (HP:0003175) | 3.29829428 |
| 31 | Hypoventilation (HP:0002791) | 3.26451131 |
| 32 | Fat malabsorption (HP:0002630) | 3.22411796 |
| 33 | Palmar hyperkeratosis (HP:0010765) | 3.18250599 |
| 34 | Broad metatarsal (HP:0001783) | 3.12882428 |
| 35 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.08492618 |
| 36 | Restlessness (HP:0000711) | 2.93386241 |
| 37 | Mesomelia (HP:0003027) | 2.83745992 |
| 38 | Increased IgE level (HP:0003212) | 2.83722276 |
| 39 | Abnormality of the ischium (HP:0003174) | 2.83250771 |
| 40 | Ectopia lentis (HP:0001083) | 2.82419823 |
| 41 | Facial shape deformation (HP:0011334) | 2.80808543 |
| 42 | Potter facies (HP:0002009) | 2.80808543 |
| 43 | Osteopenia (HP:0000938) | 2.78658314 |
| 44 | Neonatal short-limb short stature (HP:0008921) | 2.78552839 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.78210509 |
| 46 | Coronal craniosynostosis (HP:0004440) | 2.73456427 |
| 47 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.72314913 |
| 48 | Thickened calvaria (HP:0002684) | 2.70612343 |
| 49 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.69345449 |
| 50 | Plantar hyperkeratosis (HP:0007556) | 2.68183596 |
| 51 | Spinal rigidity (HP:0003306) | 2.66246070 |
| 52 | Irregular epiphyses (HP:0010582) | 2.60824191 |
| 53 | Flat capital femoral epiphysis (HP:0003370) | 2.59382207 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.57654028 |
| 55 | Thick nail (HP:0001805) | 2.56026748 |
| 56 | Hypotrichosis (HP:0001006) | 2.54500210 |
| 57 | Aortic aneurysm (HP:0004942) | 2.54225909 |
| 58 | Vitreoretinal degeneration (HP:0000655) | 2.51272831 |
| 59 | Joint stiffness (HP:0001387) | 2.49581589 |
| 60 | Popliteal pterygium (HP:0009756) | 2.49522670 |
| 61 | Increased connective tissue (HP:0009025) | 2.48809039 |
| 62 | Exercise-induced muscle cramps (HP:0003710) | 2.48414864 |
| 63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.48194782 |
| 64 | Fragile skin (HP:0001030) | 2.47413338 |
| 65 | Wormian bones (HP:0002645) | 2.46272652 |
| 66 | Turricephaly (HP:0000262) | 2.46042106 |
| 67 | Atrophic scars (HP:0001075) | 2.45538183 |
| 68 | Ankle contracture (HP:0006466) | 2.42920040 |
| 69 | Exercise-induced myalgia (HP:0003738) | 2.39301278 |
| 70 | Small epiphyses (HP:0010585) | 2.33046819 |
| 71 | Hypoplasia of the iris (HP:0007676) | 2.31899918 |
| 72 | Abnormality of the anterior chamber (HP:0000593) | 2.31441560 |
| 73 | Erythroderma (HP:0001019) | 2.31074436 |
| 74 | Cholecystitis (HP:0001082) | 2.30306385 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.30306385 |
| 76 | Bladder diverticulum (HP:0000015) | 2.29192460 |
| 77 | Short metatarsal (HP:0010743) | 2.29084561 |
| 78 | Hyperextensible skin (HP:0000974) | 2.29003461 |
| 79 | Adrenal overactivity (HP:0002717) | 2.28823427 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.28271563 |
| 81 | Vascular tortuosity (HP:0004948) | 2.28016698 |
| 82 | Cupped ribs (HP:0000887) | 2.27234369 |
| 83 | Erythema (HP:0010783) | 2.26633516 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.22861877 |
| 85 | Hyporeflexia of lower limbs (HP:0002600) | 2.22654481 |
| 86 | Round ear (HP:0100830) | 2.21391371 |
| 87 | Overgrowth (HP:0001548) | 2.19154894 |
| 88 | Craniofacial hyperostosis (HP:0004493) | 2.18145757 |
| 89 | Arterial tortuosity (HP:0005116) | 2.17265192 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 2.16740635 |
| 91 | Increased variability in muscle fiber diameter (HP:0003557) | 2.16118072 |
| 92 | Pterygium (HP:0001059) | 2.16012110 |
| 93 | Focal segmental glomerulosclerosis (HP:0000097) | 2.15824333 |
| 94 | Abnormality of dentin (HP:0010299) | 2.15043912 |
| 95 | Short hallux (HP:0010109) | 2.13737134 |
| 96 | Venous insufficiency (HP:0005293) | 2.13524753 |
| 97 | Lip pit (HP:0100267) | 2.13088722 |
| 98 | Corneal erosion (HP:0200020) | 2.12745069 |
| 99 | Vertebral compression fractures (HP:0002953) | 2.11120013 |
| 100 | Chorioretinal atrophy (HP:0000533) | 2.10753600 |
| 101 | Muscle fiber splitting (HP:0003555) | 2.10381438 |
| 102 | Obstructive sleep apnea (HP:0002870) | 2.07352263 |
| 103 | Joint laxity (HP:0001388) | 2.06033354 |
| 104 | Rib fusion (HP:0000902) | 2.02795186 |
| 105 | Biconcave vertebral bodies (HP:0004586) | 2.02789295 |
| 106 | Mesangial abnormality (HP:0001966) | 2.01572789 |
| 107 | Slender build (HP:0001533) | 2.01411332 |
| 108 | Palmoplantar keratoderma (HP:0000982) | 2.00990438 |
| 109 | Blue sclerae (HP:0000592) | 2.00883951 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 2.00832859 |
| 111 | Aplasia/Hypoplasia of metatarsal bones (HP:0001964) | 1.99921489 |
| 112 | Oral leukoplakia (HP:0002745) | 1.98900439 |
| 113 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.98751876 |
| 114 | Limb-girdle muscle atrophy (HP:0003797) | 1.98718808 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.97847751 |
| 116 | Genu recurvatum (HP:0002816) | 1.96897947 |
| 117 | Sudden death (HP:0001699) | 1.96455496 |
| 118 | Abnormality of the calf musculature (HP:0001430) | 1.94654720 |
| 119 | Lack of skin elasticity (HP:0100679) | 1.94026474 |
| 120 | Hemorrhage of the eye (HP:0011885) | 1.93988629 |
| 121 | Myotonia (HP:0002486) | 1.92706890 |
| 122 | Peritonitis (HP:0002586) | 1.90569324 |
| 123 | Pathologic fracture (HP:0002756) | 1.90568048 |
| 124 | Truncal obesity (HP:0001956) | 1.89931740 |
| 125 | Mitral regurgitation (HP:0001653) | 1.89027623 |
| 126 | Myoglobinuria (HP:0002913) | 1.88612507 |
| 127 | Precocious puberty (HP:0000826) | 1.88368449 |
| 128 | Intestinal polyposis (HP:0200008) | 1.87919202 |
| 129 | Neonatal onset (HP:0003623) | 1.86727796 |
| 130 | Exotropia (HP:0000577) | 1.86722231 |
| 131 | Follicular hyperkeratosis (HP:0007502) | 1.86226065 |
| 132 | Intestinal polyp (HP:0005266) | 1.84714783 |
| 133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84113019 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84041632 |
| 135 | Venous abnormality (HP:0002624) | 1.83939358 |
| 136 | Zonular cataract (HP:0010920) | 1.83200155 |
| 137 | Laryngomalacia (HP:0001601) | 1.81842710 |
| 138 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.81696611 |
| 139 | Annular pancreas (HP:0001734) | 1.80977734 |
| 140 | Decreased circulating renin level (HP:0003351) | 1.78764810 |
| 141 | Mitral stenosis (HP:0001718) | 1.78701413 |
| 142 | Absent eyelashes (HP:0000561) | 1.77734088 |
| 143 | Atrioventricular block (HP:0001678) | 1.77523698 |
| 144 | Infantile muscular hypotonia (HP:0008947) | 1.77103553 |
| 145 | Aortic regurgitation (HP:0001659) | 1.76275225 |
| 146 | Redundant skin (HP:0001582) | 1.75756047 |
| 147 | Ventricular tachycardia (HP:0004756) | 1.75721628 |
| 148 | Limited elbow extension (HP:0001377) | 1.75720747 |
| 149 | Patent foramen ovale (HP:0001655) | 1.75369395 |
| 150 | Bowel diverticulosis (HP:0005222) | 1.75188655 |
| 151 | Mitral valve prolapse (HP:0001634) | 1.75105953 |
| 152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74485262 |
| 153 | Mild short stature (HP:0003502) | 1.74229639 |
| 154 | Absent toe (HP:0010760) | 1.73152635 |
| 155 | Systemic lupus erythematosus (HP:0002725) | 1.72950108 |
| 156 | Round face (HP:0000311) | 1.72709898 |
| 157 | Abnormality of the axillary hair (HP:0100134) | 1.71820381 |
| 158 | Abnormality of secondary sexual hair (HP:0009888) | 1.71820381 |
| 159 | Aortic dissection (HP:0002647) | 1.71647936 |
| 160 | Flat acetabular roof (HP:0003180) | 1.71569496 |
| 161 | Delayed epiphyseal ossification (HP:0002663) | 1.69269180 |
| 162 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.68894048 |
| 163 | Goiter (HP:0000853) | 1.67232589 |
| 164 | Shallow orbits (HP:0000586) | 1.65271473 |
| 165 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.62548036 |
| 166 | Abnormality of femoral epiphyses (HP:0006499) | 1.62548036 |
| 167 | Metaphyseal cupping (HP:0003021) | 1.62508053 |
| 168 | Hip contracture (HP:0003273) | 1.60719478 |
| 169 | Short 1st metacarpal (HP:0010034) | 1.60176537 |
| 170 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.60176537 |
| 171 | Platyspondyly (HP:0000926) | 1.58389374 |
| 172 | Limited hip movement (HP:0008800) | 1.58020084 |
| 173 | Ulnar deviation of the wrist (HP:0003049) | 1.57626237 |
| 174 | Deviation of the hallux (HP:0010051) | 1.57349189 |
| 175 | Cerebral aneurysm (HP:0004944) | 1.57296574 |
| 176 | Waddling gait (HP:0002515) | 1.56595411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 4.21417248 |
| 2 | TRIB3 | 3.82771249 |
| 3 | PDGFRA | 3.57542876 |
| 4 | TGFBR1 | 3.01186897 |
| 5 | MAPK15 | 2.91063039 |
| 6 | EPHB2 | 2.89244238 |
| 7 | MAP3K3 | 2.72695534 |
| 8 | TTN | 2.72299754 |
| 9 | BMPR1B | 2.69321632 |
| 10 | PKN2 | 2.58302479 |
| 11 | PHKG2 | 2.26151472 |
| 12 | PHKG1 | 2.26151472 |
| 13 | ERN1 | 2.19183011 |
| 14 | DYRK3 | 2.16303111 |
| 15 | BUB1 | 2.06423539 |
| 16 | TESK1 | 2.03745132 |
| 17 | CDK8 | 2.00463035 |
| 18 | MAPKAPK3 | 1.92992237 |
| 19 | MAP2K6 | 1.92685793 |
| 20 | NLK | 1.89553096 |
| 21 | MAP3K6 | 1.74144013 |
| 22 | FER | 1.72959513 |
| 23 | MARK1 | 1.62759608 |
| 24 | LATS2 | 1.59780458 |
| 25 | STK24 | 1.58659266 |
| 26 | ICK | 1.57608363 |
| 27 | DMPK | 1.56382578 |
| 28 | FLT3 | 1.53777836 |
| 29 | CSNK1G3 | 1.51328727 |
| 30 | EEF2K | 1.48266957 |
| 31 | MAPK7 | 1.47681544 |
| 32 | INSRR | 1.44173393 |
| 33 | KIT | 1.38361462 |
| 34 | MET | 1.36880483 |
| 35 | CSNK1G2 | 1.35344433 |
| 36 | ARAF | 1.35177434 |
| 37 | NME1 | 1.34237205 |
| 38 | MYLK | 1.33837547 |
| 39 | OBSCN | 1.32915498 |
| 40 | MAP3K2 | 1.32049999 |
| 41 | ILK | 1.24218628 |
| 42 | LIMK1 | 1.22807742 |
| 43 | CSNK1G1 | 1.22371522 |
| 44 | EPHB1 | 1.19249194 |
| 45 | SIK2 | 1.18359247 |
| 46 | PRKD2 | 1.17734376 |
| 47 | STK38 | 1.16041500 |
| 48 | UHMK1 | 1.15187968 |
| 49 | ERBB3 | 1.14432482 |
| 50 | NTRK3 | 1.12730932 |
| 51 | MARK2 | 1.08493015 |
| 52 | PTK6 | 1.04332621 |
| 53 | MAP3K7 | 1.02082573 |
| 54 | PRKD1 | 1.00781911 |
| 55 | PRPF4B | 1.00089662 |
| 56 | TAOK1 | 0.98370668 |
| 57 | MAPKAPK5 | 0.97264175 |
| 58 | STK38L | 0.97219438 |
| 59 | RIPK1 | 0.97214139 |
| 60 | PAK3 | 0.95465363 |
| 61 | ABL2 | 0.93680847 |
| 62 | PKN1 | 0.93244328 |
| 63 | MTOR | 0.92381497 |
| 64 | PDGFRB | 0.92094137 |
| 65 | TGFBR2 | 0.91525858 |
| 66 | FGFR4 | 0.91207922 |
| 67 | RPS6KA2 | 0.90426218 |
| 68 | FGFR1 | 0.90291298 |
| 69 | GRK1 | 0.89723467 |
| 70 | PAK6 | 0.89575820 |
| 71 | MOS | 0.89267795 |
| 72 | PRKG2 | 0.88571208 |
| 73 | EPHA2 | 0.88550184 |
| 74 | LMTK2 | 0.88084446 |
| 75 | BMX | 0.87881179 |
| 76 | TIE1 | 0.87655854 |
| 77 | MAP3K9 | 0.83815664 |
| 78 | CASK | 0.83453558 |
| 79 | PAK2 | 0.82933025 |
| 80 | PINK1 | 0.81528476 |
| 81 | CSNK1A1L | 0.80431426 |
| 82 | NEK9 | 0.79543398 |
| 83 | PDPK1 | 0.76899292 |
| 84 | PLK2 | 0.76355997 |
| 85 | GSK3A | 0.75008267 |
| 86 | PTK2B | 0.73421272 |
| 87 | ROCK1 | 0.70628039 |
| 88 | AKT2 | 0.70388910 |
| 89 | KDR | 0.69645683 |
| 90 | EPHA3 | 0.68766762 |
| 91 | DYRK1B | 0.67513152 |
| 92 | WNK4 | 0.67253960 |
| 93 | DAPK3 | 0.65507661 |
| 94 | STK16 | 0.65446908 |
| 95 | SGK223 | 0.64863866 |
| 96 | SGK494 | 0.64863866 |
| 97 | WNK1 | 0.64343373 |
| 98 | PRKAA1 | 0.60027875 |
| 99 | MAP2K1 | 0.58834048 |
| 100 | MAP2K3 | 0.58699943 |
| 101 | CDC42BPA | 0.58307655 |
| 102 | BCKDK | 0.58305750 |
| 103 | CDK6 | 0.57953439 |
| 104 | GRK5 | 0.57252223 |
| 105 | ERBB4 | 0.57167566 |
| 106 | IRAK2 | 0.56952371 |
| 107 | PIM2 | 0.56597793 |
| 108 | SIK1 | 0.56494307 |
| 109 | ROCK2 | 0.54546731 |
| 110 | PTK2 | 0.54436512 |
| 111 | PAK1 | 0.52288752 |
| 112 | MAP2K2 | 0.52181184 |
| 113 | MAPK11 | 0.51441550 |
| 114 | MAPK4 | 0.51372130 |
| 115 | KSR2 | 0.50345617 |
| 116 | CDK5 | 0.49740468 |
| 117 | MAP3K10 | 0.49355691 |
| 118 | MAP3K11 | 0.48412917 |
| 119 | EPHA4 | 0.47647911 |
| 120 | PRKAA2 | 0.46709770 |
| 121 | MAPKAPK2 | 0.46554315 |
| 122 | MAP3K1 | 0.45299267 |
| 123 | RET | 0.45156094 |
| 124 | NTRK1 | 0.43655809 |
| 125 | PRKCI | 0.41478923 |
| 126 | LRRK2 | 0.41155848 |
| 127 | PRKCG | 0.40897027 |
| 128 | TRPM7 | 0.40838453 |
| 129 | PRKCH | 0.40821829 |
| 130 | HIPK2 | 0.40219772 |
| 131 | PDK4 | 0.40148939 |
| 132 | PDK3 | 0.40148939 |
| 133 | PIK3CG | 0.40083986 |
| 134 | ALK | 0.39199263 |
| 135 | RPS6KA4 | 0.38245081 |
| 136 | NEK1 | 0.37477842 |
| 137 | MST1R | 0.37179025 |
| 138 | PDK2 | 0.36534058 |
| 139 | PIK3CA | 0.36345607 |
| 140 | ADRBK1 | 0.36304534 |
| 141 | MAPK12 | 0.33833620 |
| 142 | TYRO3 | 0.31925839 |
| 143 | AKT3 | 0.31214234 |
| 144 | CAMK2G | 0.29241242 |
| 145 | PRKD3 | 0.28585088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.91584025 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.81224080 |
| 3 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.63519709 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.49682792 |
| 5 | Cocaine addiction_Homo sapiens_hsa05030 | 2.43117936 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.42990033 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.41097331 |
| 8 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.23729912 |
| 9 | Renin secretion_Homo sapiens_hsa04924 | 2.08968290 |
| 10 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.02928098 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88674249 |
| 12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.88528013 |
| 13 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85936219 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.80222139 |
| 15 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.79778507 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.78590540 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.72553261 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.71019513 |
| 19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67848387 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.67259128 |
| 21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.63196305 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.56761418 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49743281 |
| 24 | Melanogenesis_Homo sapiens_hsa04916 | 1.47699450 |
| 25 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.46215987 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36135956 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.35040893 |
| 28 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.33123250 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32808836 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.32384386 |
| 31 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.32370081 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.31523493 |
| 33 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.31464589 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30535015 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30449257 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.29875524 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.29086092 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.27752551 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27705407 |
| 40 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.26651873 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25913492 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25366745 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23279468 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.23093800 |
| 45 | Salivary secretion_Homo sapiens_hsa04970 | 1.21817816 |
| 46 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17867735 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15003685 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12227726 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.12142582 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09059362 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08865036 |
| 52 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.05405634 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04436799 |
| 54 | Insulin secretion_Homo sapiens_hsa04911 | 1.03139225 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01793404 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00566593 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00213754 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.99574023 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98038672 |
| 60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97454376 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97032272 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96174070 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.95182257 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91887272 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86792776 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86350157 |
| 67 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84912355 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.84672653 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84663773 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84125431 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83199942 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81787164 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81471071 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81385420 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.81226159 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.80935207 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80304225 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78384395 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.78033301 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77818116 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77787929 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.76617002 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76160694 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.75785101 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74661598 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72728927 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72646696 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71902567 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71280331 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71262644 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70508711 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69608514 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67595921 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.67451201 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67289184 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66891923 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65212567 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64732423 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63908293 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63309667 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63238516 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62439211 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61667989 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61397085 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60770164 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.60132899 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59972137 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58960395 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.57397472 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56584195 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56014132 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53404413 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51656993 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50949692 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50642276 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.50506059 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49617263 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46995790 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45500720 |
| 120 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45011498 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44837778 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44569359 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43176160 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38798981 |
| 125 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38076210 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37115114 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35356141 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.35254849 |
| 129 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34192315 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34008331 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.33723755 |

